Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-05-30 @ 4:56 PM
Study NCT ID:
NCT02629159
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-05
First Post:
2015-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-10
First Submit QC Date:
None
Study First Post Date:
2015-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-13
Results First Submit QC Date:
None
Results First Post Date:
2019-10-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-10-03
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-05
Last Update Post Date Type:
ACTUAL